🇺🇸 Norditropin® FlexPro® in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Norditropin® FlexPro® on 20 June 2000

Marketing authorisation

FDA — authorised 20 June 2000

Application: BLA021148
Marketing authorisation holder: NOVO NORDISK INC
Local brand name: NORDITROPIN FLEXPRO
Indication: INJECTABLE — INJECTION
Status: approved

Read official source →

Frequently asked questions

Is Norditropin® FlexPro® approved in United States?

Yes. FDA authorised it on 20 June 2000.

Who is the marketing authorisation holder for Norditropin® FlexPro® in United States?

NOVO NORDISK INC holds the US marketing authorisation.